Skip to content
Screener

Elevance Health ELV Q2 2026 earnings

Reported July 15, 2026 · Before market open

Revenue$49.8BBeat by $949.2M
EPS$7.45Beat by $1.24
Revenue estimate$48.9B
EPS estimate$6.21

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$49.3B
EPS estimate$4.66

Financials

Q2 2026

Income statement

See full
Revenue$50.5B+1.4%
Gross profit$45.0B+1.1%
Net income$1.5B-16.1%
EPS (diluted)$6.71-13.1%

Balance sheet

See full
Cash & equivalents$10.2B+19.5%
Total debt$30.7B+7.5%
Total equity$44.9B+2.7%
Total assets$126.44B+3.7%

Cash flow

See full
Operating cash flow$1.9B-6.9%
CapEx$287.0M+7.5%
Free cash flow$1.6B-9.0%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$82.77B+8.0%
Enterprise value$103.21B+4.0%
P/E16.7×+2.8×
P/S0.4×0.0×

Profitability

See full
Gross margin89.1%+0.4pp
Net margin2.5%-0.4pp
FCF margin3.2%+0.4pp

Returns & leverage

See full
Return on equity11.2%-1.3pp
Debt / equity0.7×0.0×
Current ratio1.5×+0.1×

Segments

By product

See full
Service fees$2.3B+8.3%

FAQ

When did Elevance Health report Q2 2026 earnings?
Elevance Health (ELV) reported Q2 2026 earnings on July 15, 2026 before market open.
What were Elevance Health's Q2 2026 revenue and EPS?
Elevance Health reported revenue of $49.8B and eps of $7.45 for Q2 2026.
Did Elevance Health beat estimates in Q2 2026?
Revenue beat the consensus estimate of $48.9B by $949.2M. EPS beat the consensus estimate of $6.21 by $1.24.
How did Elevance Health's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.1% from $49.8B a year earlier and eps declined 15.7% from $8.84.
Where can I find Elevance Health's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001156039-26-000058) and the 10-Q periodic report (0001156039-26-000060) directly on SEC EDGAR. The filing index links above go to sec.gov.